Marksans Pharma informs about disclosure

25 Apr 2022 Evaluate
Pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Marksans Pharma has informed that it enclosed Acquisition of Access Healthcare for Medical Products LLC.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

161.05 -2.05 (-1.26%)
27-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1639.30
Dr. Reddys Lab 1240.00
Cipla 1312.85
Zydus Lifesciences 893.45
Lupin 2147.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×